Peptide record

TPDB91383

19F-labeled octaarginine (19F-R8) F(SG)4R8 G(SG)4R8 R8 Antibacterial Antiviral Blood-Brain Barrier Cell-penetrating Peptides Tumor-homing Peptides modified_plain modified
8 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.

Standard-residue backbone model; source-recorded chemical modifications are not verified in these coordinates.

TPDB91383
19F-labeled octaarginine (19F-R8) F(SG)4R8 G(SG)4R8 R8
Antibacterial Antiviral Blood-Brain Barrier Cell-penetrating Peptides Tumor-homing Peptides
Anti-infective peptides Cancer-related peptides Delivery and barrier-penetrating peptides
AntiBP3 dbAMP DRAMP Peptipedia BBPpredict CellPPD CellPPD-MOD CPPsite3.0 PerseuCPP TumorHoPe2.0
modified_plain
Yes
A 8-aa modified multi-activity (Antibacterial, Antiviral, Blood-Brain Barrier, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
C-terminal: Amidation N-terminal: Acetylation
Sequence
Ac-RRRRRRRR-NH2
Physicochemical Analysis

Sequence-only estimates are not provided for modified or non-standard source notation. Reported molecular properties, when available, are retained below with their source records.

Chemical Descriptors
8 reviewed residue count
Amidation Activity
L Activity
Cationic Activity
Linear Activity
Acetylation Activity
N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)O NCC(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N[C@@H](CCCN=C)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCC(=O)N)C(=O)O Activity
Evidence Records 6 records
Evidence 1 Activity

Activity

Cell-penetrating Peptides

Target

CHO-K1 cells, HeLa

Source & Reference

CPPsite3.0
CPPsite3

Other

Source Activity Label Source Definition
Cell-penetrating Peptides
CPPsite3.0 experimentally validated cell-penetrating peptide annotation.
Natural residues Linear L Cationic
Synthetic
Nucleic acid (GAPDH siRNA)
Cytoplasm
Endocytosis
In vitro
CCCCCCCC
Evidence 2 Activity

Activity

Cell-penetrating Peptides

Target

Glioblastoma U251

Source & Reference

CPPsite3.0
CPPsite3

Other

Natural residues Linear L Cationic
Synthetic
Nucleic acid (siRNA and miRNA)
Cytoplasm
More than 50% of cells had anti-miRNA/R8 complexes and 68% of anti-miRNA escapes the endosome/lysosome.
Endocytosis
In vitro
CCCCCCCC
Evidence 3 Activity

Activity

Cell-penetrating Peptides

Target

HeLa, KG1a cells

Source & Reference

CPPsite3.0
CPPsite3

Other

Natural residues Linear L Cationic
Synthetic
Fluorophore (Alexa488), Protein (bovine serum albumin) and Nanoparticle (quantum dots)
Higher uptake efficiency for quantum dots
Endocytic pathway
In vitro
CCCCCCCC
Evidence 4 Activity

Activity

Cell-penetrating Peptides

Target

HeLa, KG1a cells

Source & Reference

CPPsite3.0
CPPsite3

Other

Natural residues Linear L Cationic
Synthetic
Fluorophore (Alexa488), Protein (bovine serum albumin) and Nanoparticle (quantum dots)
Higher uptake efficiency for quantum dots
Endocytic pathway
In vitro
CCCCCCCC
Evidence 5 Activity

Activity

Cell-penetrating Peptides

Target

Hl60 Cells

Source & Reference

CPPsite3.0
CPPsite3

Other

Natural residues Linear L Cationic
Synthetic
4-trifluoromethyl-L-phenylalanine (4CF3-Phe) at N terminus
Cytosol
Direct translocation via binding to GAGs
In vitro
CCCCCCCC
Evidence 6 Activity

Activity

Cell-penetrating Peptides

Target

CHO-K1 Cells

Source & Reference

CPPsite3.0
CPPsite3

Other

Natural residues Linear L Cationic
Synthetic
FAM via glycylglycine linker at N terminus
Arginine peptides (FAM-R8 and FAM-Rev) significantly penetrate cell membranes
In vitro
CCCCCCCCCCCCC
Additional Detail Fields 1 fields
CCCCCCCC CCCCCCCCCCCCC